Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell LinesMaria Pinkerneil, Günter Niegisch|Targeted Oncology|2016Cited by 57